| First Author | Efstratiadis A | Year | 2007 |
| Journal | Cell Cycle | Volume | 6 |
| Issue | 4 | Pages | 418-29 |
| PubMed ID | 17329972 | Mgi Jnum | J:130543 |
| Mgi Id | MGI:3771893 | Doi | 10.4161/cc.6.4.3838 |
| Citation | Efstratiadis A, et al. (2007) Notch, Myc and breast cancer. Cell Cycle 6(4):418-29 |
| abstractText | The involvement of Myc in the development of human breast cancer is known for quite some time, but an analogous role of Notch signaling is only now emerging from fragmented pieces of information. Recently, a Notch/Myc relationship in oncogenesis was revealed from a mouse model, in which mammary tumors are induced by the intracellular domain of Notch1 (N1(IC)). In fact, a combination of genetic and molecular data demonstrated that Myc is a direct transcriptional target of Notch1 participating as an indispensable downstream effector in N1(IC)-induced tumorigenic action. A medically-relevant correlative observation based on immunophenotyping was the coexpression of Notch1 and Myc in a significant fraction of human breast cancer specimens. A Notch1/Myc oncogenic association was also observed in T-cell acute lymphoblastic leukemia. |
